Jazz Pharmaceuticals' Lung Cancer Setback: Stock Impact
A late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Wealth building requires strategic financial planning. Explore various strategies to effectively grow your wealth.
22,302 articlesA late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Investors chase the next big moonshot, but headlines can blur reality. This guide breaks down how to assess whether s...
Investors often ask if Bitcoin should be the sole focus. This guide explains why many lean toward a Bitcoin-centric p...
Bitcoin has posted a three-quarter slide, raising questions about a possible late-year rebound. Analysts cite macro f...
A hypothetical look at britain's warren buffett pared nearly every position in a $13 billion portfolio during the fir...
As Netflix faces slowing growth, the question on investors' minds is simple: could the streamer be about to buy somet...
Five years into Andy Jassy’s tenure, a $10,000 investment in Amazon would be worth about $13,500, a gain that trails ...
A new wave of pre-IPO trading is reshaping access to private company bets. This guide breaks down why traders are flo...
A trio of blue-chip dividend payers is delivering double-digit gains and reliable income for retirees as 2026 unfolds...
Two private-credit funds unveiled exit options for locked-up investors, offering steep discounts and renewed liquidit...
A rising AI-driven marketing platform secures a NASDAQ ticker and raises over $50 million, signaling a new wave of in...
A new ElevenLabs case study shows better.com’s Betsy AI voice agent slashing origination costs by 41% in 2025 while l...